Live from the NIH registry
Studies recruiting near Huntsville right now
Top 25 of 86 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Rehabilitation & Neurological Services /ID# 248517 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
Pivotal Study for the Cardiac Performance System (CPS)
Cardiovascular Diseases
N/A
Observational 1,000 participants sought
Huntsville Hospital Heart Center — Huntsville, Alabama (3.9 mi)
· Sponsor: Sensydia Corporation
Collection and Distribution of Biospecimens for Novel Research Uses
Cancer, Healthy
N/A
Observational 10,000 participants sought
iSpecimen — Huntsville, Alabama (3.9 mi)
· Sponsor: iSpecimen Inc
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
Apogee Clinical Research, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: R1 Therapeutics
Evaluating Stairway Designs for Individuals With Vision Impairment
Vision, Low, Mobility Limitation
N/A
Interventional 65 participants sought
University of Alabama in Huntsville — Huntsville, Alabama (3.9 mi)
· Sponsor: The University of Alabama in Huntsville
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 850 participants sought
Neurocrine Clinical Site — Huntsville, Alabama (3.9 mi)
· Sponsor: Neurocrine Biosciences
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: DalCor Pharmaceuticals
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Heart Center Research Llc — Huntsville, Alabama (3.9 mi)
· Sponsor: Novartis Pharmaceuticals
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
COVID-19, COVID
N/A
Interventional 1,000 participants sought
AFC Madison — Madison, Alabama (6.1 mi)
· Sponsor: Aptitude Medical Systems
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Rehabilitation and Neurological Services /ID# 270782 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
Major Depressive Disorder, Suicidal Ideas
N/A
Interventional 240 participants sought
UAB Huntsville Regional Medical Campus — Huntsville, Alabama (3.9 mi)
· Sponsor: University of Alabama at Birmingham
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Proteinuric Kidney Diseases
Phase 2
Interventional 132 participants sought
Nephrology Consultants, LLC — Huntsville, Alabama (3.9 mi)
· Sponsor: Boehringer Ingelheim
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
Rehabilitation & Neurological Services /ID# 229969 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Huntsville, Alabama (3.9 mi)
· Sponsor: TG Therapeutics, Inc.
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Aortic Stenosis, Coronary Artery Disease
N/A
Interventional 4,000 participants sought
Huntsville Heart Center — Huntsville, Alabama (3.9 mi)
· Sponsor: University of British Columbia
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Apogee Clinical Research — Huntsville, Alabama (3.9 mi)
· Sponsor: Boehringer Ingelheim
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Alzheimer Disease
N/A
Observational 6,250 participants sought
Rehabilitation & Neurological Services — Huntsville, Alabama (3.9 mi)
· Sponsor: Eli Lilly and Company
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD)
Phase 2
Interventional 315 participants sought
University of Alabama - Huntsville Regional Medical Campus /ID# 267818 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
Pan Tumor Rollover Study
Cancer
Phase 2
Interventional 1,500 participants sought
Local Institution - 0220 — Huntsville, Alabama (3.9 mi)
· Sponsor: Bristol-Myers Squibb
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 56 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: Maze Therapeutics
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
St. Jude Clinic at Huntsville Hospital for Women & Children — Huntsville, Alabama (3.9 mi)
· Sponsor: St. Jude Children's Research Hospital
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Bipolar I Disorder, Bipolar II Disorder
Phase 2
Interventional 195 participants sought
University of Alabama - Huntsville Regional Medical Campus /ID# 272951 — Huntsville, Alabama (3.9 mi)
· Sponsor: AbbVie
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Huntsville, Alabama (3.9 mi)
· Sponsor: AstraZeneca